Estimated reading time: 8 minutes.
Key facts
- The case: Colby v. Abbott Laboratories, No. 1:26-cv-13910, a proposed class action filed November 9, 2026 in the U.S. District Court for the Northern District of Illinois.
- The products: Glucerna "1g Total Sugars" nutrition shakes in Milk Chocolate and Vanilla, sold in 10 fl. oz. bottles and multi-packs.
- The claim: The shakes contain allulose, a sweetener the lawsuit says counts as a sugar under federal labeling rules. The complaint estimates about 5 grams of allulose in Vanilla and 3.89 grams in Milk Chocolate, on top of the 1 gram of sugar on the label.
- Who it covers: Proposed classes of people who bought the shakes in California or Illinois for personal or household use.
- The backdrop: In July 2026, a federal appeals court in Chicago held that allulose is a sugar under the FDA's labeling regulation, in a case over Chobani yogurt.
- Status: Newly filed. No class has been certified, and Abbott has not yet responded in court. There is no settlement or claim form.
In this article
- What the lawsuit claims
- Who is involved
- What allulose is and why it matters
- How the complaint estimates the allulose
- The Chobani ruling behind the case
- Who the lawsuit would cover
- The legal claims explained
- What is known and what is not
- What happens next
- Frequently asked questions
What the lawsuit claims
Glucerna shakes are made for people managing diabetes. Abbott's own Glucerna website lists the 1g Total Sugars shakes as having 180 calories, 15 grams of protein, up to 6 grams of fiber and 1 gram of total sugars, and tells shoppers to "use Glucerna as part of a diabetes management plan."
The lawsuit says the 1 gram figure leaves something out. According to the complaint, every bottle also contains allulose, which it calls "a monosaccharide," or simple sugar. Because federal rules define total sugars by chemistry, the plaintiffs argue, the allulose should have been counted, and the "1g Total Sugars" statement on the front of the package is false.
The complaint describes the marketing as "a classic occurrence of health-washing," a term it uses for making products look healthier than they are. It also says the shakes "command a price premium" because of the sugar claim, and that shoppers would not have paid that much, or bought the shakes at all, had they known.
Who is involved
The plaintiffs. Sue Colby of Clovis, California says she bought a Glucerna 1g Total Sugars shake at a Walmart in Clovis on or about September 11, 2026. Jawa Hodges of Chicago bought one at a Walmart in Chicago on or about July 10, 2025, according to the complaint. Colby says she saw and relied on the label's sugar statement before buying, and the complaint says both plaintiffs paid a premium they would not otherwise have paid.
The defendant. Abbott Laboratories is an Illinois corporation headquartered in Abbott Park, Illinois. The complaint says Abbott owns the Glucerna brand and makes the shakes through its Abbott Nutrition business. It says the products are sold at Walmart, Walgreens, Target and other stores, on Abbott's own online store and on Amazon.
The lawyers. The plaintiffs are represented by Kevin Laukaitis of Laukaitis Law LLC. The complaint is dated November 6, 2026 and was filed November 9.
Check your label The case covers the Glucerna shakes labeled "1g Total Sugars" in Milk Chocolate and Vanilla. The complaint says the ingredient list on these shakes names allulose.
What allulose is and why it matters
Allulose is a sweetener that food makers use in place of table sugar because it has far fewer calories. The FDA's 2020 guidance lets companies count it at 0.4 calories per gram, compared with the 4 calories per gram used for ordinary carbohydrates.
How allulose should appear on a label has been unsettled for a decade. When the FDA updated the Nutrition Facts label in 2016, it said allulose, "as a monosaccharide, must be included in the [Total Sugars] declaration" until a future rulemaking decided otherwise. Then, in October 2020, the FDA issued guidance saying it would use "enforcement discretion," meaning it would not take action against companies that left allulose out of the Total Sugars and Added Sugars lines, "pending review of the issues in a rulemaking." That rulemaking has not happened.
FDA guidance is not binding law. Companies that followed the 2020 guidance could still face lawsuits under state consumer protection laws, and that is the opening this case uses.
The complaint also says allulose can cause stomach problems in some people, including bloating, diarrhea and abdominal pain, citing health websites and a clinical study. It says the shakes carry no warning about that. This is the plaintiffs' characterization, and the complaint does not claim either plaintiff suffered those effects.
How the complaint estimates the allulose
The lawsuit does not cite lab testing. Instead, it works backward from the numbers on the Nutrition Facts panel.
Each shake has 180 calories. The complaint subtracts the calories from fat (10 grams) and protein (15 grams), leaving about 30 calories for carbohydrates. It then subtracts the declared fiber and the 1 gram of sugar from the 14 grams of total carbohydrate and asks what the remaining grams must be.
For Vanilla, it counts 9 grams that the label does not account for, and says only about 18 calories are left to cover them. Because allulose has so few calories, the complaint calculates that about 5 of those 9 grams must be allulose. For Milk Chocolate, which has more fiber, it arrives at about 3.89 grams of allulose.
The complaint itself calls these figures "approximations" and says "testing and discovery will establish the precise allulose content." Abbott has not said how much allulose the shakes contain.
These are estimates and allegations The allulose amounts come from the plaintiffs' math, not from Abbott or a lab test. No court has found that the Glucerna label is false or misleading.
The Chobani ruling behind the case
The Glucerna suit leans heavily on Franco v. Chobani, decided July 27, 2026 by the U.S. Court of Appeals for the Seventh Circuit, the federal appeals court that covers Illinois, Indiana and Wisconsin.
That case involved Chobani Zero Sugar yogurt, which the court said had four grams of allulose per serving. A lower court had thrown the case out, deferring to the FDA's 2020 guidance. The appeals court reversed. It said the regulation defines total sugars as "the sum of all free mono- and disaccharides," and that "[t]here's no dispute that allulose is a monosaccharide." The court wrote that the FDA "defined a class by way of chemistry."
The FDA itself, invited to weigh in, told the court that the regulation is unambiguous and includes allulose, and that the 2020 guidance was an enforcement position rather than an interpretation of the rule. The court agreed and held that the 2020 guidance "isn't an interpretation" of the rule but "an announcement of a change in enforcement policy."
That matters for preemption, the legal doctrine that blocks state-law claims that go beyond federal food labeling rules. Because the Franco plaintiffs sought to enforce standards identical to the federal ones, the court let their state-law claims proceed. The Glucerna complaint is filed in the same circuit, so Franco is binding on the judge who will hear it.
The Glucerna case is part of a larger wave. A November 6, 2026 client alert from the law firm O'Melveny & Myers said plaintiffs had filed more than 130 lawsuits over allulose sugar claims in the months since Franco. A food litigation newsletter from Juris Law Group also lists an earlier case over the same Glucerna shakes, White v. Abbott Laboratories, in federal court in New York. Class Action Pulse did not review that complaint.
Who the lawsuit would cover
The complaint proposes two classes:
- California Class: "All persons who purchased Defendant's Products bearing the '1g Total Sugars' Representations in California for personal, family, or household use, and not for resale, during the applicable limitations period through the date of class certification."
- Illinois Class: the same definition for purchases made in Illinois.
Purchases for resale do not count, and the complaint excludes entities Abbott controls, government bodies, the judges on the case and people who opt out. Buyers in other states are not part of these proposed classes.
The legal claims explained
The lawsuit brings claims under California and Illinois law and says it does not try to enforce the federal food law directly:
- California Consumers Legal Remedies Act (CLRA): bans deceptive practices in consumer sales. For now, the California plaintiff seeks only a court order under this law, not money.
- California False Advertising Law and Unfair Competition Law: cover misleading advertising and unfair or unlawful business practices, and allow restitution.
- Illinois Consumer Fraud and Deceptive Business Practices Act: the main Illinois consumer protection law, which allows damages.
- Unjust enrichment: a claim, on behalf of both classes, that Abbott unfairly kept money from shoppers who paid for something other than what the label said.
The plaintiffs ask the court to certify the classes, declare Abbott's labeling unlawful and order it to stop or correct the claim. They also seek damages, punitive damages where Illinois law allows, restitution and attorneys' fees. They demand a jury trial.
No money available yet This lawsuit was just filed. There is no settlement and nothing to claim. Any payment would depend on a future settlement or verdict.
What is known and what is not
Known: the court, case number, products, proposed classes, claims and the legal backdrop.
Not known: how much allulose the shakes actually contain, how Abbott will respond, and which judge will hear the case. Class Action Pulse found no public statement from Abbott about the lawsuit.
What happens next
Abbott will likely respond with a motion to dismiss. In Franco, Chobani argued that shoppers care about the health effects of sugar rather than its chemistry, and that allulose does not have the same harmful effects as other sugars. The Seventh Circuit rejected a version of that argument at this early stage in Franco, saying how consumers understand a label is a question of fact to be tested in discovery. It also noted that Chobani planned to raise other defenses in the lower court.
If the case survives, it would move to discovery, where the allulose content could be tested, and then to class certification. That usually takes a year or more.
For a related case, see our coverage of the Liquid I.V. Sugar-Free lawsuit, or the Costco Kirkland sugar-free allulose case. You can also browse class actions you can join.
Frequently asked questions
Which Glucerna products are in the lawsuit?
Glucerna "1g Total Sugars" nutrition shakes in Milk Chocolate and Vanilla, sold in 10 fl. oz. bottles, both individually and in multi-packs. Other Glucerna products are not named.
Does the lawsuit say Glucerna raises blood sugar?
No. The complaint argues that allulose is legally a sugar and should be counted on the label. It does not claim allulose raises blood sugar like table sugar.
Is allulose bad for people with diabetes?
The lawsuit makes no medical finding about that. It cites sources saying allulose can cause stomach discomfort in some people. Talk to your doctor or dietitian about any diet questions.
Can I join the Glucerna class action?
The proposed classes cover people who bought the shakes in California or Illinois. No class has been certified, so there is nothing to sign up for. Keep receipts or order records in case a settlement is reached.
How much money could I get?
Nothing is available now. Any payment would depend on a future settlement or court judgment.
Has Abbott responded?
Class Action Pulse found no public statement or court filing from Abbott responding to the lawsuit as of November 17, 2026.

